Invest in the First Facial-Sensing Tech for Smart Glasses

Our patented sensor platform is the first to turn smart glasses into behavior-sensing devices by capturing thousands of subtle facial muscle movements in real time. This unlocks applications in health and wellbeing, medical research, consumer sentiment, and AR/VR/XR. Our platform can even provide behavioral nudges in response to real-time data.

Share Price
$1,000*
Min. Investment
$7M
Raised
$4M
Grants Awarded
OPPORTUNITY

Wearables Are a $84B Market.1 XR Could Exceed $3 Trillion.2

Wearables are already a massive $84B market, and smart glasses are the fastest-growing category, expanding 200% each year. But this is just the beginning.

Most wearables track motion, heart rate, or sleep, but they can’t tell users why they feel or behave a certain way. Emteq holds the patents for the sensing tech that smart glasses need to deliver real value. As the giants race to dominate the platform, we control a key piece they don’t have.

Smart glasses are going to replace smartphones the same way smartphones replaced computers”
Mark Zuckerberg

Meta is scaling production of smart glasses to 10 million units per year

Experts project the XR market will reach $3 trillion in the coming years

Apple and Google are building XR products, including smart glasses

Clients & Partners

Innovation

The First Tech to Measure All-Day Facial Expressions—And Change Behavior

Our patented sensor platform is the first to turn smart glasses into behavior-sensing devices by capturing thousands of subtle facial muscle movements in real time. This unlocks applications in health and wellbeing, medical research, consumer sentiment, and AR/VR/XR.

35

Patents (27 granted)

36

Peer-reviewed publications confirming sensor accuracy and expression analysis, used by neuroscience researchers to study facial responses and emotions in real-world settings.

Stanford university logoUniversity of Cambridge logoNortheastern logoUniversity of Sussex logo

Collaboration with top universities like Stanford, Northeastern, and Cambridge

BUSINESS MODEL

3 Revenue Streams:
Research. Products. Licensing.

Emteq generates revenue through a three-tier model designed for long-term growth. We advance our core technology through paid research services. We validate in market by launching targeted consumer products. And we scale by licensing our technology. We’re already seeing traction in each category.

Research & Services

  • R&D partnership with one of the world’s top gaming companies.
  • Research partnerships with leading international universities and labs, including Stanford, Northeastern, and Cambridge University.
  • Global distribution deal with Brain Products, a leading neuroscience technology provider.

Products

  • Our first diet product shows 91% of users improved their eating behavior.
  • Our partnership with Sussex University and early validation on depression opens the door to the $14B mood monitoring market.
  • In October we start development of a platform for autism emotion and social interaction training with leading expert Prof. Sir Simon Baron-Cohen.

Licensing

  • 27 patents issued with broad coverage of optical flow sensing for facial expressions in eyewear.
  • Passed technical review and now in contract negotiations with one of the biggest players in XR.
  • In technical review with one of the world’s largest consumer electronics companies.
Confident woman wearing black glasses and a white shirt, shown in close-up portraits highlighting her facial features and eyewear.A smiling man wearing glasses and a patterned shirt, close-up shots highlighting his face and positive expression.
PRODUCTS

The First Wearable That Measures How You Eat and Automatically Logs Food

Our first consumer product–Sense Eyewear–targets diet because it’s a huge problem, our tech fits into lightweight eyewear, and the $274B market is wide open. Poor diet is the world’s top health risk, but current wearables can't reliably collect the most basic data: what we eat and how we eat it.

Close-up images of a person's eyes wearing augmented reality glasses, highlighting the technology's lenses and sensors integrated into the frames.

28

Tracks 28 diet metrics like chewing speed and distracted eating through 2.8M data points

91%

of users slowed eating, which is linked to better weight and gut health

12x

Logs meals 12x easier than phones

Close-up images of a person's eyes wearing augmented reality glasses, highlighting the technology's lenses and sensors integrated into the frames.
Only Emteq technology can measure the 4 critical daily diet inputs1
Emotions2
Behaviour
Activity
Food Eaten
Emteq
Smartphone
Indirect data or surveys
Indirect data or surveys
Manually logged
Watch
Ring
CGM
Lagging indicator
  1. Other factors influencing diet and weight don’t vary across the day, such as metabolism, sleep, age, genetics, and medical conditions.
  2. Watches, rings, and phones use indirect measures to try to measure stress and other emotions (HR, HRV, sweat response, phone activity, voice, surveys, etc.).

The First Wearable That Tracks How You Feel

1 in 5 people live with a mental health disorder, but we still rely on occasional check-ins and self-reported surveys.

Our smart glasses will change that:

  • Passively track emotional responses throughout the day

  • Automatically tag mood to people, places, and activities

  • Spot patterns in what improves—or worsens— mental states

Roadmap

The Road to Category Leadership in Wearable Health

Built to lead in Health, Wearables, and XR. With the funds from this raise, we will pursue critical milestones in our three revenue categories.

  • Launch smart glasses + behavior change platform in the consumer market
  • Launch product partnerships in diet and wellness
  • Expand recurring revenue from research services
  • Expand clinical studies to support additional health use cases
  • Launch sensor miniaturization development program
  • Advance early licensing & development deals
A horizontal timeline from 2025 to 2029 showing a company's roadmap across three tracks: Research Services, Product Partnerships, and Licensing & Royalties. Key milestones include a Diet Product Launch in 2026, Sensor Miniaturization in 2027, an Emotion Product Launch in 2028, and a Sentiment Product Launch in 2029.A horizontal timeline from 2025 to 2029 showing a company's roadmap across three tracks: Research Services, Product Partnerships, and Licensing & Royalties. Key milestones include a Diet Product Launch in 2026, Sensor Miniaturization in 2027, an Emotion Product Launch in 2028, and a Sentiment Product Launch in 2029.
exıt potentıal

How Breakthrough Innovations Power Big Tech

Many of today’s breakthrough technologies began with startups like ours. When major tech companies need new capabilities such as facial data, emotion tracking, or input interfaces, they first look to acquire the innovators who have already built them versus taking the longer path of developing the solutions in-house.

Lesser-known companies are often acquired for a specific technology or function that larger companies want to incorporate into their product.

A diagram illustrating several major tech acquisitions: PrimeSense and Beats acquired by Apple. DeepMind acquired by Google. CTRL-Labs acquired by Meta.

Select AR Acquisitions

A table titled "Select AR Acquisitions" lists companies, acquirers, and prices. Google acquired Raxium for ~$1,000M and North for ~$180M. Meta acquired CTRL-labs for ~$800M, Beat Games for ~$100M's, and Within for ~$100M's. Apple acquired NextVR for ~$100M and Mira Labs for ~$50-100M. Snap acquired WaveOptics for ~$500M and NextMind for ~$80M.
How It Works

From Facial Movement to Measurable Change

Emteq’s patented optical flow sensors fit into any smart eyewear and measure subtle facial muscle movements with extreme precision, unlocking insight into diet, emotion, and behavior.

Sensing

Tiny sensors embed in glasses frames to track subtle facial muscle movements.

Interpretation

Data is processed by our AI for patterns like chewing speed, emotional state, or distracted behavior.

Response

The system delivers in-the-moment nudges – like a gentle buzz to slow down eating – designed to reinforce healthier lifestyles.

Insight

Our AI processes millions of data points each day to deliver unique insights based on your personal goals.

play video
perks

Get Investor Exclusive Benefits

Emteq’s patented optical flow sensors fit into any smart eyewear and measure subtle facial muscle movements with extreme precision, unlocking insight into diet, emotion, and behavior.

Early Investor Share Bonus
X%
Limited time left to invest
00
Days
00
Hrs
00
Mins
00
Secs
Invest
$1,000+
Receive
5%
Bonus Shares
Invest
$2,500+
Receive
8%
Bonus Shares
  • Early access to investor-only product updates
  • Exclusive virtual demo session of the Emteq device with the product team
Invest
$5,000+
Receive
12%
Bonus Shares
  • Priority access to beta hardware/software tests, and limited-edition investor merchandise
Invest
$10,000+
Receive
15%
Bonus Shares
  • Private virtual briefing with the product team
Invest
$50,000+
Receive
25%
Bonus Shares
  • VIP on-site lab tour and dinner with the founders
Team

Deep Expertise in Eyewear, Emotion, and AI/ML

Our leadership brings together deep technical expertise and real-world product experience – from academic research labs to consumer hardware giants.

Man with eyes in a white shirt.
Steen Strand
CEO

Former head of SnapLab, Snap Inc.'s augmented reality eyewear division and Snap's hardware-related investments and acquisitions. Previously founded and built consumer product startups including ICON Aircraft. MSME (Product Design), Stanford. AB Economics, Harvard.

Man in glasses and in a blue coat.
Dr. Charles Nduka
Founder & Chief Science Officer

Surgeon and leading authority on the face. Multi-award winning researcher, author of over 100 scientific papers and over 20 patents. Founded Emteq Labs to improve the delivery of personalized remote therapy using objective sensor data. MA, Oxford. MBBS, University of London. MD Imperial College.

Man with brown eyes wearing a brown blouse and a white shirt.
Dr. Hristijan Gjoreski
CTO

Professor, scientist and Al researcher, focused on application of Al algorithms to build intelligent systems and applications. Selected as top 2% scientist worldwide for last year, Best Young Scientist in Macedonia for 2017, and award winner of ML competitions. Author of >100 papers on human behavior and emotion Al.

Press Coverage

Frequently Asked Questions

 

Why invest in startups?

Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise - you are buying a piece of a company and helping it grow.

 

How much can I invest?

Accredited investors can invest as much as they want. But if you are NOT an accredited investor, your investment limit depends on either your annual income or net worth, whichever is greater. If the number is less than $124,000, you can only invest 5% of it. If both are greater than $124,000 then your investment limit is 10%.

 

How do I calculate my net worth?

To calculate your net worth, just add up all of your assets and subtract all of your liabilities (excluding the value of the person’s primary residence). The resulting sum is your net worth.

 

What are the tax implications of an equity crowdfunding investment?

We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.

 

Who can invest in a Regulation CF Offering?

Individuals over 18 years of age can invest.

 

What do I need to know about early-stage investing? Are these investments risky?

There will always be some risk involved when investing in a startup or small business. And the earlier you get in the more risk that is usually present. If a young company goes out of business, your ownership interest could lose all value. You may have limited voting power to direct the company due to dilution over time. You may also have to wait about five to seven years (if ever) for an exit via acquisition, IPO, etc. Because early-stage companies are still in the process of perfecting their products, services, and business model, nothing is guaranteed. That’s why startups should only be part of a more balanced, overall investment portfolio.

 

When will I get my investment back?

The Common Stock (the "Shares") of Emteq Labs (the "Company") are not publicly-traded. As a result, the shares cannot be easily traded or sold. As an investor in a private company, you typically look to receive a return on your investment under the following scenarios: The Company gets acquired by another company. The Company goes public (makes an initial public offering). In those instances, you receive your pro-rata share of the distributions that occur, in the case of acquisition, or you can sell your shares on an exchange. These are both considered long-term exits, taking approximately 5-10 years (and often longer) to see the possibility for an exit. It can sometimes take years to build companies. Sometimes there will not be any return, as a result of business failure.

 

Can I sell my shares?

Shares sold via Regulation Crowdfunding offerings have a one-year lockup period before those shares can be sold under certain conditions.

 

Exceptions to limitations on selling shares during the one-year lockup period:

In the event of death, divorce, or similar circumstance, shares can be transferred to:
• The company that issued the securities;
• An accredited investor;
• A family member (child, stepchild, grandchild, parent, stepparent, grandparent, spouse or equivalent, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships).

 

What happens if a company does not reach their funding target?

If a company does not reach their minimum funding target, all funds will be returned to the investors after the close of the offering.

 

How can I learn more about a company's offering?

All available disclosure information can be found on the offering pages for our Regulation Crowdfunding offering.

 

What if I change my mind about investing?

You can cancel your investment at any time, for any reason, until 48 hours prior to a closing occurring. If you’ve already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To submit a request to cancel your investment please email: info@dealmakersecurities.com

 

How do I keep up with how the company is doing?

At a minimum, the company will be filing with the SEC and posting on its website an annual report, along with certified financial statements. Those should be available 120 days after the fiscal year end. If the company meets a reporting exception, or eventually has to file more reported information to the SEC, the reporting described above may end. If these reports end, you may not continually have current financial information about the company.

 

What relationship does the company have with DealMaker Securities?

Once an offering ends, the company may continue its relationship with DealMaker Securities for additional offerings in the future. DealMaker Securities’ affiliates may also provide ongoing services to the company. There is no guarantee any services will continue after the offering ends.

Join the Discussion

Loading Comments
Share Price
Invest Now